Potentiation of platelet activation through the stimulation of P2X1 receptors.

作者: J. A. Erhardt , K. Pillarisetti , J. R. Toomey

DOI: 10.1046/J.1538-7836.2003.00453.X

关键词:

摘要: Summary.  The platelet P2X1 purinergic receptor is a ligand-gated ion channel that responds to ATP. precise role of in function unknown, though stimulation with the agonist α,β-Me-ATP known result shape change through elevation calcium levels. aim present study was examine further effects on activation. Stimulation resulted and small aggregate formation heparin-anticoagulated preparations. Given ability heparin potentiate activation, subsequent experiments were performed hirudin. In these preparations, response alone less than observed heparin; however, significantly potentiated when added conjunction other weak agonists [epinephrine or thrombopoietin (TPO)]. Platelet confirmed by single loss (microaggregate formation), microscopy, light transmittance studies. Further, antagonist MRS-2159 inhibited aggregation responses induced α,β-Me-ATP. Overall, this demonstrates can induce/potentiate activation combination agonists. These results are first demonstration mediated direct stimulation, supporting for regulating

参考文章(37)
Belén RODRÍGUEZ-LIÑARES, Steve P. WATSON, THROMBOPOIETIN POTENTIATES ACTIVATION OF HUMAN PLATELETS IN ASSOCIATION WITH JAK2 AND TYK2 PHOSPHORYLATION Biochemical Journal. ,vol. 316, pp. 93- 98 ,(1996) , 10.1042/BJ3160093
A Oda, Y Miyakawa, BJ Druker, K Ozaki, K Yabusaki, Y Shirasawa, M Handa, T Kato, H Miyazaki, A Shimosaka, Y Ikeda, Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists. Blood. ,vol. 87, pp. 4664- 4670 ,(1996) , 10.1182/BLOOD.V87.11.4664.BLOODJOURNAL87114664
Hiroshi Kojima, Yoko Hamazaki, Yuka Nagata, Kazuo Todokoro, Toshiro Nagasawa, Tsukasa Abe, Modulation of platelet activation in vitro by thrombopoietin. Thrombosis and Haemostasis. ,vol. 74, pp. 1541- 1545 ,(1995) , 10.1055/S-0038-1649979
Jean-Etienne Fabre, MyTrang Nguyen, Anne Latour, Jayne A. Keifer, Laurent P. Audoly, Thomas M. Coffman, Beverly H. Koller, Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nature Medicine. ,vol. 5, pp. 1199- 1202 ,(1999) , 10.1038/13522
Axel C. Matzdorff, Gitta Kühnel, Bettina Kemkes-Matthes, Reinhard Voss, Comparison of GP IIB/IIIA inhibitors and their activity as measured by aggregometry, flow cytometry, single platelet counting, and the rapid platelet function analyzer. Journal of Thrombosis and Thrombolysis. ,vol. 12, pp. 129- 139 ,(2001) , 10.1023/A:1012967320220
Gunther Hollopeter, Hans-Michael Jantzen, Diana Vincent, Georgia Li, Laura England, Vanitha Ramakrishnan, Ruey-Bing Yang, Paquita Nurden, Alan Nurden, David Julius, Pamela B. Conley, Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature. ,vol. 409, pp. 202- 207 ,(2001) , 10.1038/35051599
K. Mulryan, D. P. Gitterman, C. J. Lewis, C. Vial, B. J. Leckie, A. L. Cobb, J. E. Brown, E. C. Conley, G. Buell, C. A. Pritchard, R. J. Evans, Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature. ,vol. 403, pp. 86- 89 ,(2000) , 10.1038/47495
Stephen J. Wood, Lauri MacKenzie, Beverly Maleeff, Mark R. Hurle, Ronald Wetzel, Selective inhibition of Abeta fibril formation. Journal of Biological Chemistry. ,vol. 271, pp. 4086- 4092 ,(1996) , 10.1074/JBC.271.8.4086
Anthony H. Ingall, John Dixon, Andrew Bailey, Mandy E. Coombs, David Cox, Judith I. McInally, Simon F. Hunt, Nicholas D. Kindon, Barry J. Teobald, Paul A. Willis, Robert G. Humphries, Paul Leff, Jane A. Clegg, James A. Smith, Wendy Tomlinson, Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy. Journal of Medicinal Chemistry. ,vol. 42, pp. 213- 220 ,(1999) , 10.1021/JM981072S